Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lesley Scott

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Journal of Immunological Methods|July 9, 2021
Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune responseAnura David, Lesley Scott, Sarika Jugwanth, et al.
Plos One|December 16, 2017
HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional studyJenny Coetzee, Gillian Hunt, Maya Jaffer, et al.
PLOS Global Public Health|September 1, 2023
Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortalityElise De Vos, Daniel Westreich, Lesley Scott, et al.
BMC Infectious Diseases|June 12, 2016
A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countriesCatherine Godfrey, Gail Tauscher, Sally Hunsberger, et al.
Plos One|June 14, 2013
Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South AfricaColleen F Hanrahan, Katerina Selibas, Christopher B Deery, et al.
NIHR Open Research|February 11, 2025
INdependenT prEscribinG in community phaRmAcy; whaT works for whom, why and in what circumstancEs (INTEGRATE): Realist review study protocolOla Amr Abdelfatah, Andrea Hilton, Ellen Schafheutle, et al.
Journal of Clinical Microbiology|December 3, 2020
Comparative Analytical Evaluation of Four Centralized Platforms for the Detection of Mycobacterium tuberculosis Complex and Resistance to Rifampicin and IsoniazidMargaretha de Vos, Lesley Scott, Anura David, et al.
The Journal of Antimicrobial Chemotherapy|July 9, 2018
The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosisMichael G Whitfield, Robin M Warren, Vanessa Mathys, et al.
Scientific Reports|September 30, 2021
Diagnostic performance of the Abbott RealTime MTB assay for tuberculosis diagnosis in people living with HIVBelén Saavedra, Edson Mambuque, Neide Gomes, et al.
The American Journal of Tropical Medicine and Hygiene|October 7, 2011
Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literatureCatherine S Marshall, Allen C Cheng, Peter G Markey, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Journal of Immunological Methods|July 9, 2021
Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune responseAnura David, Lesley Scott, Sarika Jugwanth, et al.
Plos One|December 16, 2017
HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional studyJenny Coetzee, Gillian Hunt, Maya Jaffer, et al.
PLOS Global Public Health|September 1, 2023
Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortalityElise De Vos, Daniel Westreich, Lesley Scott, et al.
BMC Infectious Diseases|June 12, 2016
A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countriesCatherine Godfrey, Gail Tauscher, Sally Hunsberger, et al.
Plos One|June 14, 2013
Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South AfricaColleen F Hanrahan, Katerina Selibas, Christopher B Deery, et al.
NIHR Open Research|February 11, 2025
INdependenT prEscribinG in community phaRmAcy; whaT works for whom, why and in what circumstancEs (INTEGRATE): Realist review study protocolOla Amr Abdelfatah, Andrea Hilton, Ellen Schafheutle, et al.
Journal of Clinical Microbiology|December 3, 2020
Comparative Analytical Evaluation of Four Centralized Platforms for the Detection of Mycobacterium tuberculosis Complex and Resistance to Rifampicin and IsoniazidMargaretha de Vos, Lesley Scott, Anura David, et al.
The Journal of Antimicrobial Chemotherapy|July 9, 2018
The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosisMichael G Whitfield, Robin M Warren, Vanessa Mathys, et al.
Scientific Reports|September 30, 2021
Diagnostic performance of the Abbott RealTime MTB assay for tuberculosis diagnosis in people living with HIVBelén Saavedra, Edson Mambuque, Neide Gomes, et al.
The American Journal of Tropical Medicine and Hygiene|October 7, 2011
Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literatureCatherine S Marshall, Allen C Cheng, Peter G Markey, et al.
Pageof 8